{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028770","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.882585+00:00","generated_at":"2026-05-31T18:11:14.397661+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"PowerUp Acquisition terminates merger with Visiox Pharmaceuticals on July 19","bullets":["Terminated Merger Agreement with Visiox Pharmaceuticals due to failure to satisfy closing conditions by June 30, 2024.","Company intends to continue evaluating other business combination targets but provides no assurance.","Termination effective July 19, 2024; no transaction resulted.","No financial terms of the abandoned merger were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028770","json":"https://secwatch.observer/filing/0001493152-24-028770.json","markdown":"https://secwatch.observer/filing/0001493152-24-028770.md","text":"https://secwatch.observer/filing/0001493152-24-028770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/0001493152-24-028770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315224028770/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:11:14.397661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}